What I do at MMV:
As Senior Clinical Trial Manager, I am responsible for the operational planning and management of the CANTAM Phase IIIb/IV study for the drug Pyramax®, a study with sites in five African countries: Cameroun, Congo, Gabon, DR Congo and Côte d’Ivoire.
Why I work at MMV:
Working in a multicultural and multidisciplinary environment such as MMV, and collaborating with multiple partners around the world is incredibly motivating. It is a great privilege to be part of the MMV team and to contribute to the global effort to bring the burden of malaria down to zero by developing high quality and medicines that are affordable for vulnerable populations.
More about me:
I am a Biologist by training and hold a PhD from the University of Neuchatel, specializing in parasitology and infectious diseases. I completed my post-doctoral fellowship at the Centers for Disease Control and Prevention in Atlanta, during which time I participated in a mission to Kikwit (former Zaire), to conduct field research during the Ebola virus outbreak. I completed my post-graduate studies in pharmaceutical medicine at the University of Basel. Prior to joining MMV, I worked for 14 years with CROs and medical device companies in clinical research, mainly in study management. I spent the last 8 years of my career at Debiopharm International managing HCV and oncology clinical trials.
Ask me about:
Clinical research, project management and parasitology, as well as art, innovative architecture and eclectic music.